Medtronic Earns CE Mark for ApexCut Surgical Blades for ENT

Medtronic has received CE mark approval for its ApexCut surgical blades, the next generation of its powered ENT (ear, nose, and throat) instrumentation.

ApexCut blades, developed in partnership with surgeons, were engineered to reduce clogging and provide smoother, more predictable performance during powered ENT procedures. The blade’s design incorporates a new mouthpiece and tooth-to-tooth cutting pattern meant to minimize interruptions and maintain procedural flow.

“We are very excited to receive CE mark for our new ApexCut blades for sinus surgery,” said Panos Drakoulas, VP of International for the Ear, Nose, and Throat business at Medtronic. “This is a significant milestone that enables us to bring this innovative technology to surgeons across Europe, offering a seamless solution designed to support consistent performance so they can stay focused on what matters most—their patients and the procedure.”

The EU nod allows initial clinical use in Europe, with first cases anticipated shortly after approval.

“ApexCut blades are a testament to what’s possible when we listen to surgeons and innovate with purpose,” said Sean Haag, president of the Ear, Nose, and Throat business at Medtronic. “This milestone reflects our commitment to delivering solutions that empower surgeons to provide exceptional care to their patients. We’re excited to see the impact this technology will have across Europe and beyond.”

Earlier this week, the company revealed it had completed the acquisition of CathWorks, a privately-held company aiming to transform how coronary artery disease (CAD) is diagnosed and treated. The transaction was valued at $585 million.